1-8 of 8
Jan J. Schuringa, PhD
Close
Sort by
Journal Articles

Evaluation of Extrinsic and Intrinsic Cues Involved in BCR-ABL-Induced Leukemogenesis

Pallavi Suhas Sontakke, MSC, Richard W.J. Groen, PhD, Katarzyna Koczula, MSC, Jennifer Jaques, Huipin Yuan, PhD, Ulrich Günther, PhD, Anton C. Martens, PhD, Edo Vellenga, MD PhD, Jan J. Schuringa, PhD
Journal: Blood
Blood (2014) 124 (21): 515.
https://doi.org/10.1182/blood.V124.21.515.515
Published: 2014
Journal Articles

CITED2 Modulates Differentiation and Proliferation of Normal and Leukemic Hematopoietic Stem and Progenitor Cells Downstream of PU.1

Hein Schepers, Ph.D, Patrick M. Korthuis, Jan J. Schuringa, PhD, Gerald de Haan, Ph.D, Edo Vellenga, PhD
Journal: Blood
Blood (2011) 118 (21): 922.
https://doi.org/10.1182/blood.V118.21.922.922
Published: 2011
Journal Articles

Reconstructing the Human Hematopoietic Niche: Opportunities for Studying Normal and Malignant Hematopoiesis,

Richard W Groen, PhD, Willy A Noort, PhD, Reinier Raymakers, MD, PhD, Henk-Jan Prins, Msc, Linda Aalders, Frans M Hofhuis, Berris van Kessel, Petra Moerer, Henk Rozemuller, PhD, Jan J. Schuringa, PhD, Joost de Bruijn, PhD, Michel de Weers, PhD, Paul W.H.I. Parren, PhD, Henk M. Lokhorst, MD, Tuna Mutis, MD PhD, Anton CM Martens, PhD
Journal: Blood
Blood (2011) 118 (21): 3412.
https://doi.org/10.1182/blood.V118.21.3412.3412
Published: 2011
Journal Articles

Loss of Stem Cell Quiescence and Impaired Stem Cell Function of CD34 + /CD38 low Cells One Year Following Autologous Stem Cell Transplantation

Carolien M Woolthuis, Annet Z Vos, Gerwin Huls, Joost TM de Wolf, Jan J. Schuringa, PhD, Edo Vellenga, PhD
Journal: Blood
Blood (2011) 118 (21): 1893.
https://doi.org/10.1182/blood.V118.21.1893.1893
Published: 2011
Journal Articles

NF-κB and MCL-1 Are Important Determinants for the Effectiveness of Bortezomib In CD34 + AML Versus CD34 − AML Cells

Matthieu C.J. Bosman, Jan J. Schuringa, PhD, Wim J. Quax, PhD, Edo Vellenga, PhD
Journal: Blood
Blood (2011) 118 (21): 1420.
https://doi.org/10.1182/blood.V118.21.1420.1420
Published: 2011
Journal Articles

In Vivo Treatment of AML Patients with High-Dose Simvastatin Inhibits Geranylgeranylation In AML Cells

Karen van der Weide, Susan D.P.W.M. de Jonge-Peeters, Gerwin A. Huls, MD, PhD, Rudolf S.N. Fehrmann, Jan J. Schuringa, PhD, Folkert Kuipers, PhD, Elisabeth G.E. de Vries, MD, PhD, Edo Vellenga, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3280.
https://doi.org/10.1182/blood.V116.21.3280.3280
Published: 2010
Journal Articles

Gene Expression Profiling In Leukemic Stem Cell-Enriched AML CD34 + Cell Fraction Identifies Target Genes That Predict Prognosis In Normal Karyotype AML

Carolien M Woolthuis, Hendrik JM de Jonge, Annet Z Vos, Andre B Mulder, MD, Eva van den Berg, P.M. Kluin, MD, PhD, Karen van der Weide, Evelina S. De Bont, MD, PhD, Geert A Huls, MD, PhD, Edo Vellenga, MD, PhD, Jan J. Schuringa, PhD
Journal: Blood
Blood (2010) 116 (21): 952.
https://doi.org/10.1182/blood.V116.21.952.952
Published: 2010
Journal Articles

Long-Term Expansion and Self Renewal Is Contained in the CD34+, but Not the CD34- Subfraction of Nucleophosmin Mutated Acute Myeloid Leukemia Cells.

Carolien Woolthuis, Lina Han, Djoke van Gosliga, Philip Kluin, MD, PhD, Edo Vellenga, MD, PhD, Jan J. Schuringa, PhD, Geert Huls, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1349.
https://doi.org/10.1182/blood.V112.11.1349.1349
Published: 2008